Search
Enter keywords, a title or a report id number below.
Your Search for 'OTC Pharmaceuticals - Switzerland - A Snapshot (2010)' returned 33 results - Page 1 of 2
Sort by
Sorted by
Rank
Top-Bottom
-
The Pharmaceutical Market: Philippines
Espicom Business Intelligence Ltd, May 2012 , Pages: 66Manufacturers Hizon La Croesus Pharma Lloyd Laboratories Morishita-Seggs Pascual Laboratories Pharma Industries Swiss Pharma United Laboratories OTC PHARMACEUTICALS MARKET SIZE COMPETITION Company ... -
Pharmaceuticals - Global Outlook
Global Industry Analysts, Inc, Jan 2012 , Pages: 443Markets Independently Analyzed with Annual Sales Figures in US$ Billion for Years 2010 through 2015 6 Table 4: World 5-Year Perspective for Prescription Pharmaceuticals by Therapeutic Class ... -
Switzerland Pharmaceuticals and Healthcare Report Q3 2011
Business Monitor International, Jun 2011 , Pages: 88measures, the Swiss government’s focus on cost-containment within the pharmaceuticals and healthcare sector and the impact of generic competition as a result of the patent cliff, we expect Switzerland to ... -
Switzerland Pharmaceuticals and Healthcare Report Q1 2012
Business Monitor International, Jan 2012 , Pages: 85Projections - Pharmaceuticals: CHF5.88bn (US$5.64bn) in 2010 to CHF5.73bn (US$6.71bn) in 2011; -2.6% growth in local currency terms and +19.08% in US dollar terms. - Healthcare: CHF59.54bn (US$57.09bn) in ... -
Switzerland Pharmaceuticals and Healthcare Report Q2 2010
Business Monitor International, Mar 2010 , Pages: 75Switzerland Pharmaceuticals and Healthcare Report Q2 2010 Switzerland Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical ... -
Japan Pharmaceuticals and Healthcare Report Q4 2011
Business Monitor International, Aug 2011 , Pages: 109provision of healthcare and a large economy are the main attractions for drugmakers. Headline Expenditure Projections - Pharmaceuticals: JPY9,525bn (US$109.25bn) in 2010 to JPY9,664bn (US$117.88bn) in 2011 ... -
Egypt Pharmaceuticals and Healthcare Report Q4 2010
Business Monitor International, Sep 2010 , Pages: 96Egypt Pharmaceuticals and Healthcare Report Q4 2010 Business Monitor International's Egypt Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts ... -
Nigeria Pharmaceuticals and Healthcare Report Q1 2012
Business Monitor International, Nov 2011 , Pages: 101: NGN121.0bn (US$802mn) in 2010 to NGN139.3bn (US$917mn) in 2011; +15.1% in local currency terms and +14. 3% in US dollar terms. - Healthcare: NGN1,921bn (US$12.73bn) in 2010 to NGN2,221bn (US$14.6bn) in 2011 ... -
France Pharmaceuticals and Healthcare Report Q1 2011
Business Monitor International, Jan 2011 , Pages: 89towards the healthcare sector and account for a large percentage of pharmaceutical spending. On September 29 2010, the French government announced almost EUR40bn (US$55bn) of savings for the 2011 budget in ... -
Japan Pharmaceuticals and Healthcare Report Q2 2012
Business Monitor International, Feb 2012 , Pages: 94. The company will make most of the 2,800 redundancies in Europe and the US as it attempts to save US$1.7bn through the integration of US$12bn Swiss acquisition Nycomed. The acquisition of Nycomed in ... -
Japan Pharmaceuticals and Healthcare Report Q1 2012
Business Monitor International, Nov 2011 , Pages: 95Projections - Pharmaceuticals: JPY9,525bn (US$109.3bn) in 2010 to JPY9,961bn (US$126.9bn) in 2011; +4.6% in local currency terms and +16.1% in US dollar terms. Our forecast has been revised up from Q411 due ... -
Canada Pharmaceuticals and Healthcare Report Q1 2011
Business Monitor International, Jan 2011 , Pages: 88Pharmaceutical Business Environment Ratings Table: Americas – Pharmaceuticals Business Environment Ratings, Q111 Rewards Risks Canada – Market Summary Pharmacovigilance Biosimilars OTC Medicines ... -
Poland Pharmaceuticals and Healthcare Report Q2 2012
Business Monitor International, Mar 2012 , Pages: 103Poland Pharmaceuticals and Healthcare Report Q2 2012 BMI View: It is worth reiterating our view that while 2012 is set to be a challenging year for drugmakers operating in Poland, we do not believe ... -
Jordan Pharmaceuticals and Healthcare Report Q1 2011
Business Monitor International, Nov 2010 , Pages: 89and grant from Switzerland, which was signed between Swiss Confederation president Doris Leuthard and the country’s Minister of International Cooperation Jaafer Hassan in early October 2010. The funds ... -
Canada Pharmaceuticals and Healthcare Report Q1 2012
Business Monitor International, Dec 2011 , Pages: 91effective. Headline Expenditure Projections - Pharmaceuticals: CAD25.94bn (US$25.19bn) in 2010 to CAD26.30bn (US$27.39bn) in 2011; +1.3% growth in local currency terms and +8.7% growth in US dollar terms ... -
Turkey Pharmaceuticals and Healthcare Report Q4 2008
Business Monitor International, Dec 2008 , Pages: 87Turkey Pharmaceuticals and Healthcare Report Q4 2008 Having been moved to the Emerging Europe region – from Middle East and Africa (MEA) – only in the previous quarter, Turkey now occupies a joint ... -
United Arab Emirates Pharmaceuticals and Healthcare Report Q1 2011
Business Monitor International, Jan 2011 , Pages: 110United Arab Emirates Pharmaceuticals and Healthcare Report Q1 2011 The United Arab Emirates Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts ... -
Australia Pharmaceuticals and Healthcare Report Q2 2009
Business Monitor International, Apr 2009 , Pages: 110marketed by Australian CSL Biotherapies, with the two companies expecting US$13mn and US$21mn in 2009 and 2010 sales in the country, respectively. In other developments, the public healthcare scheme ... -
Brazil Pharmaceuticals and Healthcare Report Q2 2009
Business Monitor International, Apr 2009 , Pages: 98Brazil Pharmaceuticals and Healthcare Report Q2 2009 Brazil Pharmaceuticals and Healthcare Report provides independent forecasts and competitive intelligence on Brazil's pharmaceuticals and ... -
Spain Pharmaceuticals and Healthcare Report Q2 2010
Business Monitor International, Apr 2010 , Pages: 86Spain Pharmaceuticals and Healthcare Report Q2 2010 The Spain Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations ...
All rights reserved. © Copyright 2013 Research and Markets WWW4
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
